Month: <span>August 2024</span>
Month: August 2024

Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study

Neurol Ther. 2024 Aug 6. doi: 10.1007/s40120-024-00648-z. Online ahead of print. NO ABSTRACT PMID:39106033 | DOI:10.1007/s40120-024-00648-z

The changes of coagulation profiles in Kawasaki disease and its associations with clinical classification, intravenous immunoglobulin responsiveness and coronary artery involvement

Clin Exp Med. 2024 Aug 6;24(1):177. doi: 10.1007/s10238-024-01430-z. ABSTRACT Coagulation disorders are common in Kawasaki disease (KD). The main objectives of the present study were …

Letter to the editor “Neurosurgical short-term outcomes for pediatric medulloblastoma patients and molecular correlations: a 10-year single-centre observation cohort study”

Neurosurg Rev. 2024 Aug 6;47(1):406. doi: 10.1007/s10143-024-02625-4. NO ABSTRACT PMID:39105868 | DOI:10.1007/s10143-024-02625-4

Group cohesion and alliance predict cognitive-behavioral group treatment outcomes for youth with anxiety disorders

Cogn Behav Ther. 2024 Aug 6:1-19. doi: 10.1080/16506073.2024.2385906. Online ahead of print. ABSTRACT Knowledge about how to enhance group cognitive behavioral therapy (GCBT) outcomes is …

Unveiling the nexus! Understanding knowledge issues, animal contact patterns and interaction of health care providers in the context of monkeypox and COVID-19 during monkeypox outbreak 2022

Ann Med. 2024 Dec;56(1):2386452. doi: 10.1080/07853890.2024.2386452. Epub 2024 Aug 6. ABSTRACT BACKGROUND: A monkeypox (MPOX) outbreak occurred in May 2022. On June 3, 2022, the …